Cargando…

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction

Overexpression of receptor tyrosine kinases (RTK), including members of the HER family, has prognostic and therapeutic significance in invasive esophagogastric carcinoma. RTK expression in premalignant gastroesophageal lesions has not been extensively explored. Formalin-fixed paraffin-embedded tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ecker, Brett L., Taylor, Laura, Zhang, Paul J., Furth, Emma E., Ginsberg, Gregory G., McMillan, Matthew T., Datta, Jashodeep, Czerniecki, Brian J., Roses, Robert E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999185/ https://www.ncbi.nlm.nih.gov/pubmed/27559738 http://dx.doi.org/10.1371/journal.pone.0161781

Ejemplares similares

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2015)

Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer
por: Datta, Jashodeep, et al.
Publicado: (2015)

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)

Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2014)

HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
por: Ieni, A., et al.
Publicado: (2015)

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma
por: Sigrand, Julie, et al.
Publicado: (2016)

Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001)

Oncodriver inhibition and CD4(+) Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
por: Rosemblit, Cinthia, et al.
Publicado: (2018)

Band ligation for a gastroesophageal junction Dieulafoy’s lesion
por: Benatta, Mohammed Amine, et al.
Publicado: (2017)

Premalignant Lesions as Targets for Cancer Vaccines
por: Finn, Olivera J.
Publicado: (2003)

Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007)

Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas
por: Nielsen, Sofie L., et al.
Publicado: (2017)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
por: Van Cutsem, Eric, et al.
Publicado: (2014)

Zoon's Balanitis: Benign or Premalignant Lesion?
por: Balato, Nicola, et al.
Publicado: (2009)

DNA integrity in diagnosis of premalignant lesions
por: Azab, Noha Adel, et al.
Publicado: (2021)

Mast Cells and Angiogenesis in Oral Malignant and Premalignant Lesions
por: Michailidou, E.Z, et al.
Publicado: (2008)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
por: Esen, Selin Aktürk, et al.
Publicado: (2022)

HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study
por: Huang, Dan, et al.
Publicado: (2013)

Serum retinol level in patients with colorectal premalignant and malignant lesions.
por: Ostrowski, J., et al.
Publicado: (1987)

Cystitis glandularis: A controversial premalignant lesion
por: YI, XIANLIN, et al.
Publicado: (2014)

Immunological and classical subtypes of oral premalignant lesions
por: Foy, Jean-Philippe, et al.
Publicado: (2018)

Premalignant lesions and gastric cancer: Current understanding
por: Koulis, Athanasios, et al.
Publicado: (2019)

Relevance of Position and Movement of the Gastroesophageal Junction in Gastroesophageal Reflux Disease
por: Lee, Yeong Yeh
Publicado: (2013)

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
por: Shan, Ling, et al.
Publicado: (2013)

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
por: Li, Weiling, et al.
Publicado: (2022)

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
por: Radford, Maluki, et al.
Publicado: (2023)

Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
por: Datta, Jashodeep, et al.
Publicado: (2014)

Expression of cyclooxygenase-2 in gastritis and gastric premalignant lesions
por: Rossolymos, Nikolaos A., et al.
Publicado: (2013)

Benign, Premalignant, and Malignant Lesions Encountered in Bariatric Surgery
por: Raghavendra, Rao S., et al.
Publicado: (2012)

Evaluation of premalignant and malignant lesions by fluorescent light (VELscope)
por: Sawan, Dania, et al.
Publicado: (2015)

The evolving role of endoscopy in the diagnosis of premalignant gastric lesions
por: Waddingham, William, et al.
Publicado: (2018)

Telemedicine contributing to an incidental finding of a premalignant lesion
por: Maret, Delphine, et al.
Publicado: (2021)

Inflammatory microenvironment in gastric premalignant lesions: implication and application
por: Zhang, Shengxiong, et al.
Publicado: (2023)

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
por: HUANG, JUN-XING, et al.
Publicado: (2013)

Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
por: Kirschbrown, Whitney P., et al.
Publicado: (2019)

Macrophages promote the progression of premalignant mammary lesions to invasive cancer
por: Carron, Emily C., et al.
Publicado: (2017)

Gastroesophageal junction adenocarcinoma metastasizing to gingiva
por: Masamatti, Smita S, et al.
Publicado: (2013)

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
por: Kim, Jin-Jo
Publicado: (2018)

Surgical Treatment of Gastroesophageal Junction Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_95f0q5jvv12nhne6it5p2kq797